GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery

Inclusion Criteria: * Subject is scheduled to undergo elective minimally invasive (robotic or laparoscopic) surgery on the liver, including cholecystectomy * Subject is willing and able to give written informed consent for the clinical investigation participation * Subjects is 22 years of age or older at the time of enrollment; and * Subject has been informed of the nature of the clinical investigation. A subject must meet all of the following intra-operative inclusion criteria to be enrolled into the clinical investigation: * Subject undergoes a fully minimally invasive surgical approach without the use of a hand port at the time of randomization and application of the patch; * Subject in whom the Investigator is able to identify a target bleeding site at the liver resection plane for which any applicable conventional means for hemostasis (e.g. suture, ligature or cautery) are ineffective or impractical, and the choice is made to use a hemostatic agent to stop the bleeding * Pressure on the surface of the hemostatic agent can be applied with the minimally invasive instruments to achieve hemostasis * Subject has a target bleeding site with a SBSS of 1, 2, or 3 (e.g. reflecting minimal, mild or moderate bleeding severities) Exclusion Criteria: * The target bleeding site is from a large defect in an artery or vein that requires vascular reconstruction with maintenance of vessel patency * Subject is scheduled to undergo surgery on organs other than the liver and its associa…